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Abstract 
Proteins are essential compositions of the living organisms and involved in the processes of different life events. Basically 
proteins are like amazing tiny bio-machines performing the functions in a stable and predictable manner and understanding the 
underline mechanisms can facilitate the pharmaceutical development. However, protein functions are not carried in a static style, 
so experimental observations of these dynamic movements of the drugs inside the proteins are difficult, so computational 
methods have an important and irreplaceable role. 
We developed a software tool called LigandPath for mapping the ligand migration channels in a constantly moving protein and 
this software can function with CADD (Computer aided drug design) software to map the possible migration pathways of 
candidate drugs inside a protein. Traditionally, biologists use MD (Molecular Dynamics) simulation to locate the ligand 
migration channels, but it takes long time for them to observe the complete migration paths. In order to overcome the limitations 
of the trajectory-based MD simulation, we adopt a computational method inspired from robotic motion planning called DyME 
(Dynamic Map Ensemble) and we develop the software tool LigandPath based on DyME. The software tool has already been 
successfully applied to map the potential migration channels of drugs candidates of three proteins, PPAR (peroxisome 
proliferator-activated receptors), UROD (uroporphyrinogen decarboxylase) and Sirt1 (silent information regulator 1) complexes 
in three publications. 
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1. Introduction 
Proteins are the basic functional units of all living entities. Understanding the functional mechanisms of the 
protein can facilitate the bioscience development and medical advancement. Many proteins function via the binding 
of a ligand, such as the binding of substrate and cofactors in enzyme catalysis process. For many proteins, such as 
myoglobin, the binding of its ligand site lies inside the protein and there is no obvious route can pass to the internal 
binding site. It is generally believed that the ligand can go through a path opened due to dynamic disturbance, but 
exactly how the proteins exert the control is not yet entirely clear. A number of experimental observations through 
methods such as: time-resolved Laue X-ray diffraction can observe very transient phenomenon. For a longer time 
observation, molecular dynamics simulation is usually required to observe the full ligand migration path network. 
Therefore, it is essential to develop new computational tools. The new computational tools will have significant 
impacts in the CADD (computer aided drug design) research field. When a new drug is filtered out, knowing how 
the drug enters the protein, and thus reaches the binding sites is also important. Through mapping the drug migration 
network in a dynamic protein, the researchers can further predict how easy or how difficult it is for the drug to reach 
the binding site. 
In the early 70s, Case and Karplus adopted MD (molecular dynamics) simulation to study the ligand binding of 
myoglobin1, and after then, a series of studies have been done, such as Elber and Karplus2. So far, MD simulation is 
still the most widely used research method in finding the ligand migration paths. Nutt and Meuwly utilized classical 
Classical MD and QM-MD to discover ligand migration paths and the results are accordance with the infrared 
spectrum observations3. Hummer et al. used both MD simulations and time-resolved Laue X-ray diffraction to 
observe ligand migration path, and they found the results of these two methods are consistent4. Among the MD 
simulation studies, the longest simulation in finding the ligand migration path was done by Ruscio et al., and the 
overall simulation time is 5. 
In our previous study, we observed that the ligand migration in a dynamic protein is very much alike the mobile 
robot navigation in a dynamic environment. Inspired by this observation, we developed a motion planning based 
computational method called DyME (Dynamic Map Ensemble), this computational method can compute the 
possible ligand migration paths of a dynamic protein in a very efficient manner6. 
 
Fig 1: 2D Voronoi diagram 
Many robotics methods have been applied to study different biological problems, such as protein loop closure7, 8, 
the movement of protein backbone9, the protein flexibility and structural sampling10,11 and so on. In particular, 
robotic motion planning has been successfully applied to protein dynamics12-14. Our previous DyME6 approach can 
be regarded as one of the methods inspired from robotics. 
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Fig 2: The schematic view of DyME (reproduced from 6) 
DyME can be seemed as a general approach to obtain the ligand migration channels of a dynamic protein because 
it identifies the internal cavities automatically. However, in most of the cases, ligand only binds to a specific site and 
normally the binding site can be identified. For example, in CADD (computer aided drug design), the drug 
candidates and their potential binding sites can be determined in the screening process, so the binding site is already 
known, but how a candidate drug reach the binding site is unknown. Therefore, in this research, we simplified the 
original DyME and allow the users to put the ligand into the input pdb file, so the new software tool can have the 
position of the binding site before mapping the free space and we call this new software tool LigandPath. We also 
make this software tool freely available to the public and the software can be downloaded from 
http://ligandpath.mis.ncyu.edu.tw. 
2. Methods 
2.1. DyME 
DyME adopt Voronoi diagram to map free space of a single protein structure, and then construct a maximum 
clearance roadmap. Figure 1 shows a two-dimensional Voronoi diagram example. Given the coordinates of the 
atoms, Voronoi diagram divided the space into polyhedra and each polyhedron contains an atom so that the distance 
of any point to the atom in the same polyhedron is smaller than the distance of the point to the atoms in other 
polyhedra 
Figure 2 shows the schematic view of the DyME method, first we will have a protein structure ensemble as the 
input and a protein structure ensemble is a set of protein structures and these structures can come from different 
experiments or even computational method, such as: X-Ray, NMR structure or trajectories of MD simulations. 
DyME then maps the free space of each single structure. Since each single structure is a representation of a 
stationary state, we call the free space of a single structure partial map. After the free spaces of all structures are 
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mapped, DyME then integrate all partial maps into a complete map, so that a complete map can truly represent the 
possible ligand migration paths of a "dynamic" protein. 
 
Fig 3: Flow chart of DyME (reproduced from 6) 
Figure 3 shows the process of DyME method. DyME consists of four steps. In the first step, DyME construct the 
max clearance graph for each single structure and this part can be processed in parallel. In the second step, DyME 
employed DBSCAN (Density-Based Spatial Clustering of Applications with Noise15) to identify the cavities. In this 
step, two assumptions were made. The first assumption is that there is a small distance between the cavity center and 
the solvent which can allow us to separate the internal cavities and surface pockets. The second assumption is that 
the internal cavities appear more frequently than normal channels in a dynamic protein, so when all max clearance 
graphs superimposed together, we will have different densities in the channel and cavities such that DBSCAN can 
be used to identify the internal cavities. The third step employs DBSCAN to find the surface portals. The fourth step 
integrates the max clearance graphs of the whole protein ensemble based on the identified cavities and portals to 
become a super graph, so the final super graph can represent the max clearance paths available when the protein 
dynamics is considered. 
2.2. Design of LigandPath 
The DyME automatically identifies the possible cavities inside a protein using the internal free space. In order to 
correctly identify the cavities, two assumptions were made. The first assumption is that a cavity is at least some 
distance away from the solvent. This helps us to distinguish a cavity from a surface pocket. The second assumption 
is that the cavities should appear more frequently and with higher clearance than the channels connecting them. The 
second assumption allows us to distinguish cavities from open channels. These two assumptions were purely for 
automating the cavity identification process. However, for candidate drugs identified using CADD software, the 
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binding site information is available, so the cavity identification process in DyME is redundant for CADD related 
research. Therefore, a simplified DyME for CADD research is developed in this paper. The developed software tool 
is called LigandPath. LigandPath is also equipped with a better user interface and accept more MD trajectory 
formats. Figure 4 shows design of the LigandPath. 
 
Fig 4 Design of LigandPath 
Table 1 shows the comparison between the DyMe and LigandPath. The functionality of auto cavity identification 
is removed in LigandPath,so LigandPath has better performance than DyME. LigandPath also supports more MD 
trajectory formats and is public available. 
Table 1 Comparison between DyME and LigandPath 
 DyME LigandPath 
Auto cavity identification Yes No 
Better performance No Yes 
Supporting MD trajectory formats NAMD NAMD Gromacs Accelrys DS 
Integrated with CADD No Yes 
Public available No Yes 
2.3. The Efficiency of DyME and LigandPath 
When comparing trajectory-based MD methods with DyME/LigandPath, most trajectory-based MD methods 
explicitly simulate the ligand and each simulation runs tens or perhaps even hundreds of nanoseconds to find one 
ligand migration pathway. Multiple simulations have to be executed in order to find more pathways. However, 
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DyME/LigandPath does not explicitly follow the ligand movements, so the requirement for the coordination 
between the ligand motion and the protein fluctuation through random diffusion is removed. In DyME/LigandPath, 
we only need to examine the dynamics of protein long enough to see the transient channels open once and this is 
many times shorter than the simulation time needed to see a ligand actually traversing through these channels. In 
previous research6, we use a 10-ns MD simulation to generate a ligand migration channel graph that is comparable 
to a cumulative 7- trajectory-based MD simulation. 
3. Results and Discussions 
The LigandPath program has been employed to identify the potential drug migration channel networks of 
peroxisome proliferator-activated receptors (PPAR) in 16, uroporphyrinogen decarboxylase (UROD) in 17 and silent 
information regulator 1 (Sirt1) complexes in 18. Conformations from the MD trajectories form the protein structural 
ensembles which encoded the dynamic information over a given period of time. Pathways computed using the first 5 
ns conformations were assigned as entries and those computed from the last 5 ns conformations were designated as 
exits. 
3.1. Ligand pathways of PPARs 
LigandPath has been successfully used to obtain the potential ligand migration pathways of Peroxisome 
proliferator-activated receptors (PPARs) in 16. PPARs are essential regulators of adipogenesis, lipid and 
carbohydrate metabolism, and are potential drug targets for metabolic syndromes. There are three isoforms: PPAR-
- - . Two ligands, (S)-Tryptophan-betaxanthin and berberrubine, have higher docking scores 
than the control compound and also show stable interactions during MD simulations16. 
The MD simulation trajectories were used to map the possible migration pathways. Figure 5 shows the pathways 
of the control compound and the screened ligands in three isoforms, PPAR- - d PPAR-
LigandPath maps the free space inside the protein at every conformation during the first 5 ns and the last 5 ns of MD 
simulations, respectively. Within each PPAR isoforms, similar portals and pathways are identified for different 
ligands. The different paths in the first 5 ns and the last 5 ns of MD simulations may be due to the possible effect of 
each ligand docking. 
Table 2 shows the running time, memory requirement and runtime environment of LigandPath for a 5ns MD 
trajectory (2000 frames) of PPAR. It takes 6 hours to complete the whole run on a PC with Intel Core i5 CPU and 4 
GB memory. The running time can be affected by the size of the protein and large proteins normally take more time 
to compute. Since the programs are written in Matlab, the Matlab Compiler Runtime environment is needed for 
executing the program. 
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Fig 5 Ligand pathways for PPAR- - - s and last 5 ns, 
respectively (reproduced from 16) 
Table 2 Running time, memory requirement and runtime environment of LigandPath for a 5ns MD trajectory (2000 frames) of PPAR  
 LigandPath 
Running time 6 hrs 45 mins 
Memory requirement 4 GB 
Runtime environment Matlab Compiler Runtime V7.14 
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Fig 6. Snapshots of simulated channels for selected ligands to the binding site in UROD. Liagnd migration channels for (A) Coproporphyrinogen 
III (B) isopraeroside IV (C) scopolin (D) nodakenin are showed. Pathways calculated from MD confirmations during 0 5 ns are marked in blue 
and assigned as entry pathways. Pathways calculated from MD confirmations during the last 5 ns are marked in magenta and assigned as exit 
pathways (reproduced from 17)
Fig 7 Ligand pathways for Sirt1 complexes with (a) cambinol, (b) (S)-tryptophan-betaxanthin, (c) 5-O-feruloylquinic acid, and (d) RosA. Notes: 
Paths and portals are shown in green and magenta for first 5 ns (A) and last 5 ns (B), respectively (reproduced from 18)
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3.2. Ligand pathways of UROD 
LigandPath has been successfully used to obtain the potential ligand migration pathways of Uroporphyrinogen 
decarboxylase (UROD) in 17. UROD has been suggested as a tumor-selective protectant for head and neck cancer 
(HNC) against radiation. Four ligands, Coproporphyrinogen III, isopraeroside IV, scopolin and nodakenin are 
sceened to have possible inhibitory effects on UROD 17. Figure 6 illustrates that all CADD screened ligands might 
be able to access to the designated binding site through pathways and pathways based on UROD 
conformations obtained from the initial and final 5 ns of MD simulation. 
3.3. Ligand pathways of Sirt1 complexes 
LigandPath has been successfully used to obtain the potential ligand migration pathways of Silent information 
regulator 1 (Sirt1) complexes in 18. Sirt1, one member of the sirtuin family, play an Important role in metabolic 
disease and diseases associated with aging. (S)-tryptophan-betaxanthin, cambinol, 5-O-feruloylquinic acid, and 
RosA were identified as potential drugs to bind Sirt1 protein 18. Figure 7 shows the possible migration channels for 
each protein ligand complex. The free space inside the protein from LigandPath at the first 5 ns and last 5 ns of MD 
simulation illustrates the possible docking effect of screened ligands and control compound on Sirt1 protein. For 
Cambinol and (S)-tryptophan-betaxanthin, the similar trajectories of A4 for Cambinol and A5 and A6 for (S)-
tryptophan-betaxanthin disappeared after MD simulation. Paths A3 and A4 in RosA also disappeared after MD 
simulation. Cross examinations of all possible migration channels show that A2 is the stable pathway for all ligands 
in Sirt1 protein and B2 for Cambinol, A2 and B3 for (S)-tryptophan-betaxanthin, A1 and B1 for 5-O-feruloylquinic 
acid, and A2 and B3 for RosA. 
4. Conclusion 
In this paper, we develop a software tool called LigandPath for mapping the ligand migration pathways in a 
dynamic protein. LigandPath can cooperate with the CADD software to map the possible migration pathways of 
candidate drugs. LigandPath has been successfully applied to map the potential drug migration channels of three 
proteins, peroxisome proliferator-activated receptors (PPAR) 16, uroporphyrinogen decarboxylase (UROD) 17 and 
silent information regulator 1 (Sirt1) complexes 18, in three publications. Potential drug migration pathways of the 
three proteins were identified and some of the potential pathways exhibit stable behaviours which can be further 
verified. Understanding the drug migration channel is important because it might affect the percentage of the drugs 
that actually reach the binding site and the percentage will indirectly influence the effectiveness of the potential 
drugs. 
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